P55210 (CASP7_HUMAN) Homo sapiens (Human)
Caspase-7 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
47 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| The crystal structure of caspase-7 in complex with Acetyl-LDESD-CHO |
Heteromer P36114; | |||||
| Assess | ||||||
| Crystal structure of unliganded caspase-7 |
Heteromer | |||||
| Assess | ||||||
| Caspase-7 in Complex with DARPin C7_16 |
Heteromer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX |
Heteromer P98170; | |||||
| Assess | ||||||
| Crystal Structure of the Caspase-7 / XIAP-BIR2 Complex |
Heteromer P98170; | |||||
| Assess | ||||||
| Crystal structure of Chromobacterium violaceum effector CopC in complex with host calmodulin and ca… |
Heteromer P0DP23; Q7NWF2; | |||||
| Assess | ||||||
| Caspase-7 S239E Phosphomimetic |
Heteromer | 3×FMT; | ||||
| Assess | ||||||
| Caspase-7 in Complex with DARPin D7.18 |
Heteromer | |||||
| Assess | ||||||
| Caspase-7 in complex with Ac-ATS009-KE |
Heteromer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP |
Heteromer P98170; | |||||
| Assess | ||||||
| Caspase-7 in complex with Ac-DW3-KE |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of caspase-7 DEVE peptide complex |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of Caspase-7 with inhibitor AC-DQMD-CHO | homo-4-mer | 1×CIT; | ||||
| Assess | ||||||
| Crystal Structure of caspase-7 with inhibitor AC-ESMD-CHO | homo-4-mer | 1×CIT; | ||||
| Assess | ||||||
| Crystal Structure of caspase-7 with inhibitor AC-DMQD-CHO | homo-4-mer | 1×CIT; | ||||
| Assess | ||||||
| Crystal Structure of Caspase-7 with inhibitor AC-IEPD-CHO | homo-4-mer | 1×CIT; | ||||
| Assess | ||||||
| Caspase-7 Variant 2 (V2) with reprogrammed substrate specificity due to Y230V/W232M/Q276C substitut… | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 Variant 1 (V1) with reprogrammed substrate specificity due to Y230A/W232M/S234N substitut… | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 Variant 2 (V2) with reprogrammed substrate specificity due to Y230V/W232M/Q276C substitut… | homo-4-mer | |||||
| Assess | ||||||
| Crystal Structure of Caspase-7 with Inhibitor AC-WEHD-CHO | homo-4-mer | 1×CIT; | ||||
| Assess | ||||||
| Caspase-7 wild-type bound to the caspase-6 cognate tetrapeptide inhibitor Ac-VEID-cho | homo-4-mer | |||||
| Assess | ||||||
| Crystal Structure of Caspase-7 incomplex with Acetyl-YVAD-CHO | homo-4-mer | |||||
| Assess | ||||||
| Crystal Structure of Caspase-7 with inhibitor AC-DNLD-CHO | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 Variant 1 (V1) with reprogrammed substrate specificity due to Y230A/W232M/S234N substitut… | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 Variant 4 (V4) with reprogrammed substrate specificity due to Y230V/W232Y/S234V/Q276D sub… | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 Variant 4 (V4) with reprogrammed substrate specificity due to Y230V/W232Y/S234V/Q276D sub… | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 in complex with elongated ketomethylene inhibitor | homo-4-mer | |||||
| Assess | ||||||
| Caspase-7 in complex with ketomethylene inhibitor reveals tetrahedral adduct | homo-4-mer | |||||
| Assess | ||||||
| Crystal structure of human procaspase-7 | homo-2-mer | 5×SO4; | ||||
| Assess | ||||||
| Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[(2-acetylphenyl)sulfanyl]b… | homo-2-mer | 1×8YM; | ||||
| Assess | ||||||
| Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-{[2-(4-chlorophenyl)-2-oxoe… | homo-2-mer | 1×8YJ; | ||||
| Assess | ||||||
| Caspase-7 bound to substrate mimic and allosteric inhibitor | homo-2-mer | 1×8YJ; | ||||
| Assess | ||||||
| Crystal structure of Caspase-7 | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of mutant form of Caspase-7 | homo-2-mer | |||||
| Assess | ||||||
| Caspase-7 in complex with DICA allosteric inhibitor | homo-2-mer | 3×SO4; 2×NXN; | ||||
| Assess | ||||||
| Crystal structure of procaspase-7 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of caspase-7 | homo-2-mer | |||||
| Assess | ||||||
| Mature Caspase-7 I213A with DEVD-CHO inhibitor bound to active site | homo-2-mer | |||||
| Assess | ||||||
| A designed redox-controlled caspase-7 | homo-2-mer | 6×FMT; | ||||
| Assess | ||||||
| Crystal Structure of mutant form of Caspase-7 | homo-2-mer | |||||
| Assess | ||||||
| CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR | homo-2-mer | 2×FXN; | ||||
| Assess | ||||||
| Caspase-7 bound to novel allosteric inhibitor | homo-2-mer | 1×SE1; | ||||
| Assess | ||||||
| Crystal structure of CASPASE-7 in Complex with allosteric inhibitor | homo-2-mer | 2×0TE; | ||||
| Assess | ||||||
| Human procaspase-7/caspase-7 heterodimer bound to Ac-DEVD-CMK | homo-2-mer | 2×CL; | ||||
| Assess | ||||||
| Human procaspase-7 bound to Ac-DEVD-CMK | homo-2-mer | 2×CL; | ||||
| Assess | ||||||
| Caspase-3 specific unnatural amino acid peptides | monomer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-CHO | monomer | 1×SO4; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3r5k.1.A | homo-2-mer | 0.76 | 99.34 | |||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 5v6u.1.A | homo-2-mer | 0.68 | 73.73 | ||
| Assess | ||||||
| Isoform 3 | 3r5k.1.A | homo-2-mer | 0.76 | 99.34 | ||
| Assess | ||||||
| Isoform 4 | 3r5k.1.A | homo-2-mer | 0.77 | 96.74 | ||
| Assess | ||||||